Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 417.00
-15.00 (-3.47%)
Apr 17, 2026, 3:30 PM JST
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 8 billion as of April 17, 2026. Its market cap has increased by 38.27% in one year.
Market Cap
8.00B
Enterprise Value
8.20B
Revenue
579.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
417.00
Market Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has increased from 4.63B to 8.00B, an increase of 72.91%. That is a compound annual growth rate of 3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 8.00B | 17.42% |
| Dec 30, 2025 | 6.81B | 18.93% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 8.92B |
| K Pharma,Inc. | 8.81B |
| MEDINET | 7.99B |
| CellSource | 7.96B |
| StemCell Institute | 7.95B |
| ADR120S | 7.36B |
| Chiome Bioscience | 7.30B |
| PRISM BioLab Co.,LTD | 7.20B |